| Dr David M Barker, MD | |
|
929 Spring Creek Rd Ste 102, Chattanooga, TN 37412-3974 | |
| (423) 629-9743 | |
| (423) 629-9744 |
| Full Name | Dr David M Barker |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 929 Spring Creek Rd Ste 102, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104801216 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 37131 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galen Medical Group, Pc | 2668377391 | 126 |
News Archive
Varian Medical Systems is introducing a new brachytherapy applicator for treating endometrial cancer patients after a hysterectomy. The Capri applicator, aimed at increasing patient comfort and allowing clinicians to better sculpt the radiotherapy dose, is being exhibited this week at the annual American Brachytherapy Society meeting in San Diego.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Maryland Department of Health and other health partners to investigate a case of monkeypox in a traveler who returned to the United States from Nigeria.
Also in the news, the Senate approves legislation to reauthorize federal research and intervention activities to lower the rate of premature births.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
› Verified 6 days ago
| Entity Name | Galen Medical Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346250057 PECOS PAC ID: 2668377391 Enrollment ID: O20031204001027 |
News Archive
Varian Medical Systems is introducing a new brachytherapy applicator for treating endometrial cancer patients after a hysterectomy. The Capri applicator, aimed at increasing patient comfort and allowing clinicians to better sculpt the radiotherapy dose, is being exhibited this week at the annual American Brachytherapy Society meeting in San Diego.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Maryland Department of Health and other health partners to investigate a case of monkeypox in a traveler who returned to the United States from Nigeria.
Also in the news, the Senate approves legislation to reauthorize federal research and intervention activities to lower the rate of premature births.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
› Verified 6 days ago
| Entity Name | Advanced Diagnostic Imaging Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093741464 PECOS PAC ID: 7315848140 Enrollment ID: O20040115000677 |
News Archive
Varian Medical Systems is introducing a new brachytherapy applicator for treating endometrial cancer patients after a hysterectomy. The Capri applicator, aimed at increasing patient comfort and allowing clinicians to better sculpt the radiotherapy dose, is being exhibited this week at the annual American Brachytherapy Society meeting in San Diego.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Maryland Department of Health and other health partners to investigate a case of monkeypox in a traveler who returned to the United States from Nigeria.
Also in the news, the Senate approves legislation to reauthorize federal research and intervention activities to lower the rate of premature births.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
› Verified 6 days ago
| Entity Name | Obgyn Centre Of Excellence |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699796169 PECOS PAC ID: 9931185253 Enrollment ID: O20040628000621 |
News Archive
Varian Medical Systems is introducing a new brachytherapy applicator for treating endometrial cancer patients after a hysterectomy. The Capri applicator, aimed at increasing patient comfort and allowing clinicians to better sculpt the radiotherapy dose, is being exhibited this week at the annual American Brachytherapy Society meeting in San Diego.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Maryland Department of Health and other health partners to investigate a case of monkeypox in a traveler who returned to the United States from Nigeria.
Also in the news, the Senate approves legislation to reauthorize federal research and intervention activities to lower the rate of premature births.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David M Barker, MD 4976 Alpha Ln, Hixson, TN 37343-5470 Ph: (423) 308-0280 | Dr David M Barker, MD 929 Spring Creek Rd Ste 102, Chattanooga, TN 37412-3974 Ph: (423) 629-9743 |
News Archive
Varian Medical Systems is introducing a new brachytherapy applicator for treating endometrial cancer patients after a hysterectomy. The Capri applicator, aimed at increasing patient comfort and allowing clinicians to better sculpt the radiotherapy dose, is being exhibited this week at the annual American Brachytherapy Society meeting in San Diego.
Scientists at the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute have been awarded a $5.1 million grant from the California Institute for Regenerative Medicine to advance the development of a novel therapy for blinding retinal conditions.
Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Maryland Department of Health and other health partners to investigate a case of monkeypox in a traveler who returned to the United States from Nigeria.
Also in the news, the Senate approves legislation to reauthorize federal research and intervention activities to lower the rate of premature births.
CTI BioPharma Corp. today announced that results of a Phase 2 study of pacritinib, in patients with myelofibrosis were published in the journal Blood. Pacritinib is a next-generation oral JAK2/FLT3 multikinase inhibitor currently in Phase 3 development in the PERSIST program.
› Verified 6 days ago
John Sindos Adams Sr., MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 929 Spring Creek Road, Suite 104, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 | |
Dr. Alicia Renee Allen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1651 Gunbarrel Rd Ste 201, Chattanooga, TN 37421 Phone: 423-899-9133 Fax: 423-855-8176 | |
Dr. Charles Patrick Johnson, DO Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1751 Gunbarrel Rd, Suite 101, Chattanooga, TN 37421 Phone: 423-778-8558 Fax: 423-778-8560 | |
Dr. William Joel Moss, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1755 Gunbarrel Rd, Suite 205, Chattanooga, TN 37421 Phone: 423-756-0863 Fax: 706-937-2377 | |
Mr. Gary A. Brunvoll, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 7490 Ziegler Rd, Chattanooga, TN 37421 Phone: 423-648-6020 Fax: 423-648-6025 | |
Elizabeth Maria Bowers, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1751 Gunbarrel Road, Suite 100, Chattanooga, TN 37421 Phone: 423-778-9500 Fax: 423-778-8882 | |
Porche' Warren Adams, DO, MPH Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 935 Spring Creek Rd Ste 100, Chattanooga, TN 37412 Phone: 423-510-0250 Fax: 423-510-9524 |